Highest reported visual acuity after electronic retinal implantation
Jasmina Cehajic Kapetanovic, Nicole Troelenberg, Thomas L Edwards, Kanmin Xue, James D Ramsden, Alfred Stett, Eberhart Zrenner, Robert E MacLaren
Acta Ophthalmologica | WILEY | Published : 2020
PURPOSE: To report the highest attained visual acuity with an electronic retinal implant for the treatment of advanced retinal degeneration following a novel intensive period of visual training. METHODS: A case study as part of the prospective, international, multi-centre, interventional clinical trial (ClinicalTrials.gov NCT02720640 and NCT01024803) of patients with the Retina Implant Alpha AMS (Retina Implant AG, Reutlingen, Germany) for advanced retinal degeneration. A patient with subretinal device implanted into worse-seeing eye with no useful perception of light vision secondary to USH2A retinal degeneration underwent intensive period of visual training. RESULTS: The device remains fun..View full abstract
The study is sponsored by the University of Oxford NIHR Biomedical Research Centre and funded by the National Institute for Health Research (UK) Invention for Innovation (i4i) Award. JCK is funded by Global Ophthalmology Fellowship Awards Programme, Bayer, Switzerland.r Financial support was received from the Invention for Innovation Award, National Institute for Health Research, United Kingdom; Oxford University Hospitals NHS Foundation Trust Biomedical Research Centre; and Nuffield Medical Fellowship. E.Z. was supported by the German Research Council Excellence Cluster 307 (Centre of Integrated Neuroscience), Retina Implant AG, and the Tistou and Charlotte Kerstan Foundation. E.Z.: Grants, personal fees, non-financial support from Retina Implant AG, Kusterdingen, Germany; E.Z. has a patent on Subretinal Implant Technology issued and a patent on Retina Implant concepts pending. AT and AS were previously employed by Retina Implant, AG, Reutlingen, Germany.